Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Medulloblastoma × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Medulloblastoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 18 Etoposide 12 Cisplatin 11 Temozolomide 10 Vincristine 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Filgrastim 8 Irinotecan 7 Carboplatin 7 X-Rays 6 Phantoms, Imaging 6 Topotecan 5 Specimen Handling 5 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Thiotepa 4 Radiation 4 Lomustine 4 Biopsy 4 Bevacizumab 4 tipifarnib 3 sargramostim 3 palbociclib 3 Methotrexate 3 HhAntag691 3 Chemotherapy, Adjuvant 3 ulixertinib 2 tazemetostat 2 sonidegib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡